Success Story: A Strategic RFE Response Secures NIW Approval for a Cardiac MRI Researcher
Client’s Testimonial:
"It's been a great pleasure to work with you.”
On May 6th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Ph.D. Student in the Field of Biomedical Imaging (Approval Notice).
General Field: Biomedical Imaging
Position at the Time of Case Filing: Ph.D. Student
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: May 6th, 2026
Processing Time: 12 months, 8 days (Premium Processing Requested)
Case Summary:
Cardiovascular disease remains one of the most urgent health challenges in the United States, creating a pressing need for better diagnostic tools that can detect cardiac injury earlier, reduce uncertainty in treatment decisions, and improve long-term patient outcomes. For this I-140 NIW case, North America Immigration Law Group (Chen Immigration Law Associates) worked with a biomedical imaging researcher from China whose proposed endeavor centered on developing high-precision medical imaging technologies for the earlier diagnosis and more personalized management of severe cardiovascular conditions.
At the time of filing, the client was a Ph.D. student whose work addressed persistent barriers in clinical diagnostic technologies: data degradation and systemic inaccuracies. The petition framed this research as a highly practical solution to urgent national healthcare challenges. By improving the reliability and quantitative precision of these complex diagnostic systems, the client’s work directly enables more accurate patient monitoring, reduces the need for unnecessary invasive procedures, and optimizes the allocation of high-cost medical resources.
The original petition was filed on April 28th, 2025, and Premium Processing was requested on November 19th, 2025. After USCIS issued a Request for Evidence on January 16th, 2026, our team prepared a detailed response clarifying the national importance of the proposed endeavor and the client’s strong positioning to advance it. The response emphasized that the client’s research was not limited to a single laboratory or institution, but was connected to broader clinical, federal, and scientific priorities in cardiovascular imaging.
To document his professional standing, our team highlighted an objective record of achievement, including 8 peer-reviewed journal articles, 35 conference abstracts, and 1 accepted peer-reviewed paper. The case also highlighted 47 citations, placing the client in the top 1% for research productivity and top 8% for citation impact, and completed at least 15 reviews for leading journals and conferences in MRI and cardiovascular imaging.
The RFE response further strengthened the record by showing that the client’s work had already drawn significant external validation, including contributions to federally supported research through major federal-level grants. It also explained how the client’s methods were being applied in patient-facing translational studies, including work involving quantitative diagnostic biomarkers, adaptive medical workflows, and advanced imaging protocols.
One recommender summarized the practical value of the client’s work clearly:
“By improving imaging quality, [Client] has strengthened the reliability and clinical usefulness, and efficiency of medical imaging technology.”
This expert support was paired with objective evidence of independent reliance, including citations by researchers developing next-generation imaging systems and refining methods for detecting complex diseases. Together, these materials helped demonstrate that the client had already influenced the direction of biomedical imaging research and was well-positioned to continue advancing nationally important work.
Following our comprehensive RFE response, USCIS approved the petition. This approval reflects how a carefully prepared petition and response can connect highly technical biomedical imaging research to concrete national benefits, including improved cardiovascular diagnosis, stronger clinical workflows, and more efficient healthcare delivery in the United States.